These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

701 related items for PubMed ID: 29029794

  • 1. Rho-kinase inhibition reverses impaired Ca2+ handling and associated left ventricular dysfunction in pressure overload-induced cardiac hypertrophy.
    Olgar Y, Celen MC, Yamasan BE, Ozturk N, Turan B, Ozdemir S.
    Cell Calcium; 2017 Nov; 67():81-90. PubMed ID: 29029794
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of mevalonate pathway prevents ischemia-induced cardiac dysfunction in rats via RhoA-independent signaling pathway.
    Yang Y, Rong X, Lv X, Jiang W, Yang Y, Lai D, Xu S, Fu G.
    Cardiovasc Ther; 2017 Oct; 35(5):. PubMed ID: 28665545
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Ellagic Acid Prevents Ca2+ Dysregulation and Improves Functional Abnormalities of Ventricular Myocytes via Attenuation of Oxidative Stress in Pathological Cardiac Hypertrophy.
    Yamasan BE, Mercan T, Erkan O, Ozdemir S.
    Cardiovasc Toxicol; 2021 Aug; 21(8):630-641. PubMed ID: 33909254
    [Abstract] [Full Text] [Related]

  • 5. Orai1 Channel Inhibition Preserves Left Ventricular Systolic Function and Normal Ca2+ Handling After Pressure Overload.
    Bartoli F, Bailey MA, Rode B, Mateo P, Antigny F, Bedouet K, Gerbaud P, Gosain R, Plante J, Norman K, Gomez S, Lefebvre F, Rucker-Martin C, Ainscough JFX, Kearney MT, Bruns AF, Shi J, Appleby HL, Young RS, Shawer HM, Debant M, Gomez AM, Beech DJ, Foster R, Benitah JP, Sabourin J.
    Circulation; 2020 Jan 21; 141(3):199-216. PubMed ID: 31906693
    [Abstract] [Full Text] [Related]

  • 6. [The expression of Rho/Rho kinase of cardiac muscle in heart failure rats caused by pressure overload and the intervention of fasudil].
    Zhang M, Qu C, Zeng DY.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Jan 21; 33(1):73-6. PubMed ID: 15924788
    [Abstract] [Full Text] [Related]

  • 7. Shen'ge powder decreases the cardiomyocyte hypertrophy in chronic heart failure by activating the Rho protein/Rho-associated coiledcoil forming protein kinase signaling pathway.
    Yan X, Jiao K, Song X.
    J Cell Biochem; 2019 Mar 21; 120(3):3038-3045. PubMed ID: 30474257
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effect of angiotensin converting enzyme inhibitor on the calcium transients and calcium handling proteins in ventricular myocytes from rats with heart failure.
    Wang LC, Ma H, He JG, Liao XX, Chen WF, Leng XY, Ma L, Mai WY, Tao J, Zeng WT, Liu J, Dong YG, Tang AL, Feng C.
    Chin Med J (Engl); 2005 May 05; 118(9):731-7. PubMed ID: 15899134
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Low-dose combination of Rho kinase and L-type Ca(2+) channel antagonists for selective inhibition of depolarization-induced sustained arterial contraction.
    Porras-González C, González-Rodríguez P, Calderón-Sánchez E, López-Barneo J, Ureña J.
    Eur J Pharmacol; 2014 Jun 05; 732():130-8. PubMed ID: 24680953
    [Abstract] [Full Text] [Related]

  • 15. CaMKIIδC Drives Early Adaptive Ca2+ Change and Late Eccentric Cardiac Hypertrophy.
    Ljubojevic-Holzer S, Herren AW, Djalinac N, Voglhuber J, Morotti S, Holzer M, Wood BM, Abdellatif M, Matzer I, Sacherer M, Radulovic S, Wallner M, Ivanov M, Wagner S, Sossalla S, von Lewinski D, Pieske B, Brown JH, Sedej S, Bossuyt J, Bers DM.
    Circ Res; 2020 Oct 09; 127(9):1159-1178. PubMed ID: 32821022
    [Abstract] [Full Text] [Related]

  • 16. Polydatin attenuates cardiac hypertrophy through modulation of cardiac Ca2+ handling and calcineurin-NFAT signaling pathway.
    Ding W, Dong M, Deng J, Yan D, Liu Y, Xu T, Liu J.
    Am J Physiol Heart Circ Physiol; 2014 Sep 01; 307(5):H792-802. PubMed ID: 25015961
    [Abstract] [Full Text] [Related]

  • 17. Altered calcium transient and development of hypertrophy in beta2-adrenoceptor overexpressing mice with and without pressure overload.
    Schwarz B, Percy E, Gao XM, Dart AM, Richardt G, Du XJ.
    Eur J Heart Fail; 2003 Mar 01; 5(2):131-6. PubMed ID: 12644002
    [Abstract] [Full Text] [Related]

  • 18. Nanoscale reorganization of sarcoplasmic reticulum in pressure-overload cardiac hypertrophy visualized by dSTORM.
    Hadipour-Lakmehsari S, Driouchi A, Lee SH, Kuzmanov U, Callaghan NI, Heximer SP, Simmons CA, Yip CM, Gramolini AO.
    Sci Rep; 2019 May 27; 9(1):7867. PubMed ID: 31133706
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Mechanisms of favorable effects of Rho kinase inhibition on myocardial remodeling and systolic function after experimental myocardial infarction in the rat.
    Mera C, Godoy I, Ramírez R, Moya J, Ocaranza MP, Jalil JE.
    Ther Adv Cardiovasc Dis; 2016 Feb 27; 10(1):4-20. PubMed ID: 26490279
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.